2016, Number 3
<< Back Next >>
Arch Neurocien 2016; 21 (3)
Aminoácidos inhibidores para principiantes
Avila-Rojas H, Pérez NI
Language: Spanish
References: 13
Page: 49-51
PDF size: 164.02 Kb.
Text Extraction
No abstract.
REFERENCES
El Mundo. 2016. Hallan más ingredientes para la vida en el cometa de la sonda Rosetta. Disponible en: http://www.elmundo.es/ciencia/2016/05/30/574c13e9e5fdea081d8b4612.html Accesado el 21 de julio del 2016.
Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatr 2005;57: 252-60.
Fatemi SH, Stary JM, Earle JA, Araghi-Nikman M, Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and reelin proteins in cerebellum. Schizophr Res 2005;72:109-22.
Jiang E, Yan X, Weng HR. Glial glutamate transporter and glutamine synthetase regulate GABAergic synaptic strength in the spinal dorsal horn. J Neurochem 2012;121:526-36.
Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. Altered cortical expression of GABA-related genes in schizophrenia: illnes progression vs developmental disturbance. Schizophr Bull 2015;41: 180-91
Hide TM, Lipska BK, Ali T, Mathew SV, Law AJ, Metitiri OE, Straub RE, Ye T, Colantuoni C, Herman MM, Bigelow LB, Weinberger DR, Kleinman JE. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical developmental and Schizophrenia. J Neurosci 2011;31: 11088-95.
Labrie V, Roder JC. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neurosci Biobehav Rev 2010;34: 351-72.
Burnet PW, Hutchinson L, von Hesling M, Gilbert EJ, Brandon NJ, Rutter AR, Hutson PH, Harrison PJ. Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia. Schizophr Res 2008;102: 283-94.
Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF, D’Souza C, Saksa J, Woods SW, Javitt DC. High dose D-serine in the treatment of schizophrenia. Schizophr Res 2010;121: 125-30.
Millan MJ. N-methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 2005;179: 30-53.
Javitt DC. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 2007;78: 69-108.
Kretschmer BD. Role of glycine in Schizophrenia. En: Schmidt WJ, Reith MEA, Eds. Dopamine and glutamate in psychiatric disorders. Nueva Jersey: Humana Press; 2005, 181-195.
Zafra F, Giménez C. Glycine transporters and synaptic function. IUBMB Life 2008;60: 810-7.